Treatment of Wegener's granulomatosis with Imuran

      This paper is only available as a PDF. To read, Please Download here.


      A patient with Wegener's granulomatosis experienced a remarkable regression on continuous therapy with Imuran®, with control of lesions in sinuses, lungs and kidneys after one year.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Klinger N.
        Grenzformen der Periarteritis nodosa.
        Frankfurt. Ztschr. Path. 1931; 42: 455
        • Wegener F.
        Ueber generalisierte, septische Gefäserkrankungen.
        Verhandl. deutsch. path. Gesellsch. 1936; 29: 202
        • Wegener F.
        Ueber eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arterien Systems und der Nieren.
        Beitr. path. Anat. 1939; 102: 36
        • Walton E.W.
        Giant-cell granuloma of respiratory tract (Wegener's granulomatosis).
        Brit. M. J. 1958; 2: 265
        • Tuhy J.E.
        • Maurice G.L.
        • Niles N.R.
        Wegener's granulomatosis.
        Am. J. Med. 1958; 25: 638
        • Felson B.
        Less familiar roentgen patterns of pulmonary granulomas.
        Am. J. Roentgenol. 1959; 81: 211
        • Bischoff M.E.
        Noninfectious necrotizing granulomatosis: pulmonary roentgen signs.
        Radiology. 1960; 75: 752
        • Sproul E.E.
        Wegener's and lethal midline granulomatosis.
        J.A.M.A. 1961; 177: 921
        • Beidleman B.
        Wegener's granulomatosis. Prolonged therapy with large doses of steroids.
        J.A.M.A. 1963; 186: 67
        • Rundles R.W.
        • Laszlo J.
        • Itoga T.
        • Hobson J.B.
        • Garrison Jr., F.E.
        Clinical and hematologic study of 6-(1-methyl-4-nitro-5-imidazolyl thiopurine) (B.W. 57–322) and related compounds.
        Cancer Chemo. Reports. 1961; 14: 99
        • Aisenberg A.C.
        Drugs employed for the suppression of immunologic responsiveness.
        New England J. Med. 1965; 272: 1114
        • Calne R.Y.
        Inhibition of the rejection of renal homografts in dogs by purine analogues.
        Transplantation Bull. 1961; 28: 65
        • Nathan H.C.
        • Bieber S.
        • Elion G.B.
        • Hitchings G.H.
        Detection of agents which interfere with the immune response.
        Soc. Exper. Biol. & Med. 1961; 107: 796
        • Murray J.E.
        Human kidney transplant conference. Transplantation. 3. 1964: 147
        • Bouroncle B.A.
        • Doan C.A.
        Treatment of refractory idiopathic thrombocytopenic purpura and acquired hemolytic anemia with Imuran.
        New England J. Med. 1966; 275: 630
        • Greenspan E.M.
        Cyclophosphamide-prednisone therapy of lethal midline granuloma.
        J.A.M.A. 1965; 193: 162
        • von Leden H.
        • Schiff M.
        Antimetabolite therapy in lethal midline granuloma.
        Arch. Otolaryng. 1964; 80: 460